Trasis
Trasis was founded in 2004 by Gauthier Philippart and Jean-Luc Morelle, the designers of the first radiosynthesisers to combine high-yield synthesis and GMP.
They put together their expertise and their knowledge of the radiopharmaceutical industry and founded Trasis, an innovative and forward-looking company. Trasis now has a track-record in developing instruments and methods recognized throughout the world.
At Trasis we are dedicated to helping the medical community access new radio-labelled therapeutic and diagnostic substances easily and faster. To this end, we design, manufacture, sell, and support high performance synthesisers, dose preparation equipment, their shielding, and accessories. We also develop customised synthetic methods and instruments. We can provide GMP Active Pharmaceutical Ingredients (API) and assist our customers with their regulatory affairs.
Our proven radiopharmaceutical expertise, coupled with our high-end instruments allows us to provide fully integrated solutions for an effective tracer production and faster transition from drug development to marketing authorization.
Our equipment is used worldwide in nuclear medicine departments, research centers, radiopharmaceutical production facilities, and pharmaceutical companies.
